The Successful Experiment
July 18, 2018
Sitting Down With… Mike Thompson, Chief Executive, Association of the British Pharmaceutical Industry (ABPI), UK.
1 min read
Jul
Manufacture
Bioprocessing - Upstream & Downstream
Technology and Equipment
Bioprocessing
Biopharma
Facilities & Equipment
Technology & Manufacturing
It’s a Vendor’s Life: Lessons Learned with Rick Morris
July 18, 2018
Despite initially envisioning a career in the polymer and textiles industry, Rick Morris now builds equipment for biopharma manufacturers – and he loves it.
1 min read
At the Immuno-Oncology Frontier
July 18, 2018
The use of the body’s own immune system to fight cancer – immuno-oncology – has seen great progress over the last decade, with a number of big pharma companies working to further advance the field in the next ten years. Here, we learn more from Bryan (Bo) Barnhart, Senior Director of Immuno-Oncology at Bristol-Myers Squibb.
1 min read
Business & Regulation
Analytical Science
Bioprocessing - Single Use Systems
Standards & Regulation
Bioprocessing
Biopharma
Regulation & Standards
Business & Trends
Sponsored
Maintaining the Analytical Edge
July 18, 2018
Working across life sciences, performance materials and healthcare divisions, Site Management Analytics is Merck’s internal solutions provider for tough analytical challenges. Here, we learn more from Christoph Saal, Director, Site-Management Analytics Healthcare, and Saskia Haehn, Manager, E&L and Packaging Materials.
1 min read
All Eyes on Biopharma Trends
July 18, 2018
What are the hot topics in biopharma manufacture? What are the challenges? And where do we need to go? We provide hard data, expert insight, and thoughts for the future in a three part series. Here, we present Part 1.
1 min read
Manufacture
Business Practice
Standards & Regulation
Small Molecules
Quality & Compliance
Trends & Forecasts
Business & Trends
Regulation & Standards
Small Molecules
Make China Great Again
July 18, 2018
China is on course to reclaim its historical position as the world’s largest economy by 2050. But the Chinese government, not satisfied with this trajectory, wants to modernize its economy and occupy the highest parts of global production chains – including pharma – much sooner. Will “Made in China 2025” succeed? We speak with industry insiders, consultants and academics to find out where The Red Dragon is headed – and what non-Chinese pharma companies need to know.
1 min read
Faster, Cheaper, Better
July 18, 2018
Are catalysts being fully exploited in small molecule drug manufacture to reduce costs and boost process speed?
1 min read
Discovery & Development
Standards & Regulation
Formulation
Drug Delivery
Regulation & Standards
Business & Trends
Formulation
Drug Delivery
The End of “Mini-Me” Medicine
July 18, 2018
Pediatric drug formulation has historically lagged behind the adult counterpart. Have government regulations had the right impact?
1 min read
Business & Regulation
Standards & Regulation
Business Practice
Trends & Forecasts
Regulation & Standards
Business & Trends
Ireland’s Brexit Trump Card
July 18, 2018
Despite the Trump administration’s tax cuts coming into force and Brexit on the horizon, Ireland’s biopharmaceutical sector will continue to thrive.
1 min read
Discovery & Development
Contract Development Services
Contract Manufacturing Services
Outsourcing
Technology & Manufacturing
Trials of a Medicine Maker
July 18, 2018
Outsourcing Buffer Management is Smart Thinking
1 min read
Browse by Topics
Interview
Drug Discovery
Development & Clinical
Formulation
Drug Delivery
Bioprocessing
Small Molecules
Cell & Gene
Facilities & Equipment
Outsourcing
Packaging
Supply Chain
Regulation & Standards
Industry News
Research News
Sitting Down With
Innovation Awards
Business & Trends
Technology & Manufacturing
Biopharma
Future of Pharma
Latest
Blog